Pulpotomy Clinical Trial
Official title:
Clinical Study of the Direct Pulp Capping in Primary Teeth
Verified date | March 2024 |
Source | The Dental Hospital of Zhejiang University School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Research content: select the patients with accidental pulp exposure or decayed pulp exposure in the pediatric dentistry department of The Affiliated Stomatology Hospital of Zhejiang University School of Medicine from February 2022 to October 2022. 1. Strictly implement the case selection criteria to reduce the deviation. 2. Conduct uniform training and assessment for doctors. 3. Record in detail: the age, gender, tooth position, cavity type, x-Ray examination, size and reason of pulp exposure, time of hemostasis, filling material, signs and symptoms of initial consultation and follow-up, etc. 4. Analyze the clinical data to study the success rate of direct pulp capping of primary teeth; analyze the influence of various factors to study how to improve the success rate of direct pulp capping of primary teeth.
Status | Completed |
Enrollment | 40 |
Est. completion date | October 31, 2023 |
Est. primary completion date | October 31, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 4 Years to 8 Years |
Eligibility | Inclusion Criteria: - No irreversible signs or symptoms of pulpitis in the affected tooth. - Mechanical pulp exposure caused by cavity preparation or trauma, or pulp exposure after decayed tissue removal, with healthy dentin around the pulp exposure. - The size of the exposed pulp<1 mm. - The morphology of pulp tissue at the pulp exposure is normal, and the bleeding should be able to be controlled within 5 minutes. - X-ray showed that there was no abnormal resorption or fracture of the root and no lesions around the root. Exclusion Criteria: - The child is unable to cooperate with the treatment. - Pulp exposure > 1 mm. - Irreversible signs or symptoms of pulpitis in the affected tooth. - Abnormal morphology of the pulp tissue at the pulp exposure, much bleeding and inability to stop bleeding. - X-ray shows: abnormal resorption or fracture of the tooth root and lesions around the root. - The parents or the child refused to participate in the experiment. |
Country | Name | City | State |
---|---|---|---|
China | The Affiliated Hospital of Stomatology, Zhejiang University School of Medicine | Hangzhou | Zhejiang |
Lead Sponsor | Collaborator |
---|---|
The Dental Hospital of Zhejiang University School of Medicine |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Success rate of the direct pulp capping | The success rate of the direct pulp capping of primary teeth | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01878851 -
Characterization of Blood Drawn From the Pulp of Primary Molar Undergoing Pulpotomy or Pulpectomy.
|
||
Completed |
NCT04270318 -
Sodium Hypoclorite as an Antibacterial Agent Prior to Pulpotomies
|
N/A | |
Completed |
NCT04909827 -
3D-printed Endocrowns Versus Prefabricated Zirconia Crowns in Pulpally-treated Primary Molars
|
Phase 4 | |
Completed |
NCT03200938 -
Clinical Applicability of PBS® CIMMO Cement in Pulpotomies
|
N/A | |
Recruiting |
NCT04863222 -
Clinical and Radiographic Success of MTA vs Biodentine
|
Phase 4 | |
Active, not recruiting |
NCT05554952 -
Indirect Pulp Capping Versus Pulpotomy With MTA for Treatment of Primary Molars With Deep Caries
|
N/A | |
Completed |
NCT03779698 -
BiodentineTM Versus Formocresol Pulpotomy Technique in Primary Molars
|
Phase 4 | |
Completed |
NCT03395496 -
Comparison of Biodentine and MTA Pulpotomies in the Primary Molar Teeth 3 Year Follow up
|
Early Phase 1 | |
Not yet recruiting |
NCT05747300 -
Wellroot PT Versus MTA in Pulpotomy of Primary Molars
|
N/A | |
Not yet recruiting |
NCT06288477 -
Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol
|
N/A | |
Not yet recruiting |
NCT06219824 -
Clinical and Radiographic Evaluation of Bioceramic Putty MTA Versus MTA in Pulpotomy of Immature Permanent Molars
|
Phase 3 | |
Completed |
NCT03718676 -
Pulpotomy With Various MTA Materials and Ferric Sulphate
|
N/A | |
Recruiting |
NCT05279820 -
Comparative Study of the Outcome of Partial and Full Pulpotomy in Irreversible Pulpits
|
N/A | |
Active, not recruiting |
NCT02298504 -
Vital Pulp Treatment in Primary Teeth
|
Phase 4 | |
Completed |
NCT04010929 -
Efficacy of Er,Cr:YSGG Laser in Partial Pupotomy
|
N/A | |
Terminated |
NCT02783911 -
Comparison of Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies
|
N/A | |
Withdrawn |
NCT02393326 -
Biodentine Partial Pulpotomy of Pulpally Exposed Primary Molars
|
N/A | |
Completed |
NCT05792748 -
Comparison of Zinc Oxide Eugenol to Ferric Sulphate Pulpotomy in Primary Teeth
|
N/A | |
Completed |
NCT05680285 -
Evaluation of Low Level Laser Therapy in Primary Tooth Pulpotomy Treatment
|
N/A | |
Completed |
NCT03782714 -
Low-level Laser Therapy Versus Formocresol in Primary Molar Pulpotomies
|
N/A |